Applied Therapeutics Inc
Applied Therapeutics Inc logo
APLT

Applied Therapeutics Inc (APLT)

$0.87947.44%

Live
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$0.86
Day's Range
$0.9696
$0.4995
52-Week Range
$11.87
1 month return22.75%
3 month return34.92%
1 year return91.72%
5 year return95.39%

Company Information

Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company's lead drug candidate, AT-007, is a novel central nervous system penetrant aldose reductase inhibitor (ARI) for the treatment of Galactosemia, a rare pediatric metabolic disease. The Company initiated a pivotal Phase 1/2 clinical trial in June 2019, read out positive top-line biomarker data in adult Galactosemia patients in January 2020 and announced full data from the trial in April 2020. A pediatric Galactosemia study commenced in June 2020. The Company is also developing AT-001, a novel potent ARI that is being developed for the treatment of Diabetic Cardiomyopathy, or DbCM, a fatal fibrosis of the heart. The Company initiated a Phase 3 registrational study in DbCM in September 2019. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of diabetic retinopathy, as well as novel dual PI3k inhibitors in preclinical development for orphan oncology indications.
OrganizationApplied Therapeutics Inc
Employees26
CEODr. Shoshana Shendelman Ph.D.
IndustryBiotechnology

Analyst Recommendation

based on 7 analysts ratings

Buy
85%
Buy
0%
Hold
14%
Sell

Based on 7 Wall street analysts offering stock ratings for Applied Therapeutics Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 1207.71%

Current

$0.88

Target

$11.5

Recommendation Trend

Based on 7 analyst

Current1M Ago3M Ago
Buy
6
9
9
Hold
0
2
2
Sell
1
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
43.3M
Book Value
$0.2
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-4.0
Wall Street Target Price
11.5

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
4.5
Enterprise Value
-1488046
Enterprise Value/Revenue
0.0
Enterprise Value/Ebitda
0.02

Technicals

Beta
1.52
50 Day MA
0.81
200 Day MA
1.38

Institutional Holdings

Franklin Resources Inc

9.94%

Alyeska Investment Group, L.P.

9.07%

Orbimed Advisors, LLC

8.84%

FMR Inc

8.34%

Point72 Asset Management, L.P.

5.9%

Knoll Capital Management LP

2.25%

Discover more

Frequently Asked Questions

What is Applied Therapeutics Inc share price today?

Can Indians buy Applied Therapeutics Inc shares?

How can I buy Applied Therapeutics Inc shares from India?

Can Fractional shares of Applied Therapeutics Inc be purchased?

What are the documents required to start investing in Applied Therapeutics Inc stocks?

What are today’s High and Low prices of Applied Therapeutics Inc?

What are today’s traded volumes of Applied Therapeutics Inc?

What is today’s market capitalisation of Applied Therapeutics Inc?

What is the 52 Week High and Low Range of Applied Therapeutics Inc?

How much percentage Applied Therapeutics Inc is down from its 52 Week High?

How much percentage Applied Therapeutics Inc is up from its 52 Week low?

What are the historical returns of Applied Therapeutics Inc?

Who is the Chief Executive Officer (CEO) of Applied Therapeutics Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*